| Product Code: ETC6738498 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to rely on key suppliers for budesonide inhalers, with Puerto Rico, Metropolitan France, Germany, Spain, and Italy leading the way. Despite a negative Compound Annual Growth Rate (CAGR) of -2.06% from 2020 to 2024, the market saw a significant decline in growth rate from 2023 to 2024 at -26.63%. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market landscape. Understanding these trends can offer insights for stakeholders navigating the competitive landscape of budesonide inhaler imports in China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Budesonide Inhaler Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Budesonide Inhaler Market Revenues & Volume, 2021 & 2031F |
3.3 China Budesonide Inhaler Market - Industry Life Cycle |
3.4 China Budesonide Inhaler Market - Porter's Five Forces |
3.5 China Budesonide Inhaler Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Budesonide Inhaler Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.7 China Budesonide Inhaler Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.8 China Budesonide Inhaler Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 China Budesonide Inhaler Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Budesonide Inhaler Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory disorders in China |
4.2.2 Growing awareness about the benefits of using inhalers for respiratory conditions |
4.2.3 Rising demand for advanced and effective treatment options in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 Competition from alternative treatment options such as traditional Chinese medicine |
4.3.3 Pricing pressures due to the presence of generic budesonide inhalers in the market |
5 China Budesonide Inhaler Market Trends |
6 China Budesonide Inhaler Market, By Types |
6.1 China Budesonide Inhaler Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Budesonide Inhaler Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Budesonide Inhaler Market Revenues & Volume, By Nebulizer, 2021- 2031F |
6.1.4 China Budesonide Inhaler Market Revenues & Volume, By Inhalants, 2021- 2031F |
6.2 China Budesonide Inhaler Market, By Dosage |
6.2.1 Overview and Analysis |
6.2.2 China Budesonide Inhaler Market Revenues & Volume, By Dry Powder, 2021- 2031F |
6.2.3 China Budesonide Inhaler Market Revenues & Volume, By Spray, 2021- 2031F |
6.2.4 China Budesonide Inhaler Market Revenues & Volume, By Suspension, 2021- 2031F |
6.2.5 China Budesonide Inhaler Market Revenues & Volume, By Aerosols, 2021- 2031F |
6.3 China Budesonide Inhaler Market, By Strength |
6.3.1 Overview and Analysis |
6.3.2 China Budesonide Inhaler Market Revenues & Volume, By 0.25mg, 2021- 2031F |
6.3.3 China Budesonide Inhaler Market Revenues & Volume, By 0.5mg, 2021- 2031F |
6.3.4 China Budesonide Inhaler Market Revenues & Volume, By 1.0mg, 2021- 2031F |
6.4 China Budesonide Inhaler Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 China Budesonide Inhaler Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 China Budesonide Inhaler Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5 China Budesonide Inhaler Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Budesonide Inhaler Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 China Budesonide Inhaler Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 China Budesonide Inhaler Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Budesonide Inhaler Market Import-Export Trade Statistics |
7.1 China Budesonide Inhaler Market Export to Major Countries |
7.2 China Budesonide Inhaler Market Imports from Major Countries |
8 China Budesonide Inhaler Market Key Performance Indicators |
8.1 Patient adherence rate to budesonide inhaler therapy |
8.2 Number of healthcare professionals prescribing budesonide inhalers |
8.3 Rate of adoption of budesonide inhalers in rural areas of China |
9 China Budesonide Inhaler Market - Opportunity Assessment |
9.1 China Budesonide Inhaler Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Budesonide Inhaler Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.3 China Budesonide Inhaler Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.4 China Budesonide Inhaler Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 China Budesonide Inhaler Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Budesonide Inhaler Market - Competitive Landscape |
10.1 China Budesonide Inhaler Market Revenue Share, By Companies, 2024 |
10.2 China Budesonide Inhaler Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here